Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2025-12-24 @ 4:15 PM
NCT ID:
NCT00328666
Eligibility Criteria:
Inclusion Criteria:
* Subjects must be willing to, and have the capacity for, giving written informed consent.
* Between the ages of 18 and 70
* Blood pressure (BP) criteria: systolic blood pressure (SBP) of \> 130 but \< 160 mm Hg and diastolic blood pressure (DBP) \< 100 mmHg
* All subjects must be willing to comply with all study-related procedures.
Exclusion Criteria:
* Female subjects who are pregnant or post partum \< 3 months
* Subjects currently taking blood pressure lowering medications or dietary supplements (magnesium, potassium, calcium \> 1200 mg/day, fish oils \> 2000 mg/day, ephedra, hawthorn, forskolin)
* Non-dominant arm circumference \> 50 cm
* Subjects with body mass index (BMI) \>= 40.0 or \< 18.5 kg/m2
* Subjects who have practiced IY in the last 12 months or those who have practiced any form of yoga \> 2 times (2x)/month in the previous 6 months.
* Subjects who have received an experimental drug, used an experimental medical device within 30 days prior to screening, or who gave a blood donation of greater than or equal to one pint within 8 weeks prior to screening.
* Subjects with diabetes mellitus
* Subjects with established cardiovascular disease
* Subjects with known arrhythmias such as atrial flutter or fibrillation or those with cardiac pacemakers
* Current users (within the previous 30 days) of any tobacco products
* History of renal insufficiency based on estimated glomerular filtration rate \< 60 ml/min
* Women who consume \> 10 alcoholic drinks per week and men who consume \> 15 drinks per week.
* Subjects with known autonomic neuropathy (e.g: Shy-Drager, orthostatic hypotension)
* Subjects with known secondary causes of hypertension (renal artery stenosis, pheochromocytoma, coarctation of aorta, hyperaldosteronemia)
* Regular use of benzodiazepines, anti-psychotic drugs or corticosteroids (\> 1x per month). Stable doses (3 months) of antidepressants (selective serotonin reuptake inhibitors \[SSRIs\] or tricyclic antidepressants \[TCAs\]) will be allowed.
* Known severe musculoskeletal problems such as spinal stenosis that may limit participation in yoga
* Subjects who actively practice (\> 2x/month) other mind-body therapy (MBT) such as Qigong, Tai Chi, or meditation.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT00328666
Study Brief:
Protocol Section:
NCT00328666